Amphastar Pharmaceuticals, Inc. (AMPH) Free cash flow 2016–2025
Amphastar Pharmaceuticals, Inc. (AMPH) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
$121.2MFY2025 · since FY2016: $17.2M → $121.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $121.2M | -29.7% |
| FY2024 | $172.3M | +18.6% |
| FY2023 | $145.3M | +123.1% |
| FY2022 | $65.1M | -7.6% |
| FY2021 | $70.5M | +201.3% |
| FY2020 | $23.4M | +11209.7% |
| FY2019 | $207,000 | +102.4% |
| FY2018 | -$8.6M | -309.7% |
| FY2017 | $4.1M | -76.1% |
| FY2016 | $17.2M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More AMPH financial trends
AMPH RevenueAMPH Net incomeAMPH Net marginAMPH Gross profitAMPH Gross marginAMPH Operating incomeAMPH Operating marginAMPH Operating cash flowAMPH Capital expendituresAMPH Return on equityAMPH Stock buybacksAMPH Dividends paidAMPH Total assetsAMPH Total liabilitiesAMPH Shareholders’ equityAMPH overview →